Immunoglobulin G4 related disease+3
Not yet recruitingStudy on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease
Study on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease
- Disease:Immunoglobulin G4 related diseaseDermatomyositis+2
- Substances:Filgotinib
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Filgotinib









